Australia Research Antibodies Market Size & Outlook
Australia research antibodies market, 2018-2030 (US$M)
Related Markets
Australia research antibodies market highlights
- The Australia research antibodies market generated a revenue of USD 49.4 million in 2023 and is expected to reach USD 69.1 million by 2030.
- The Australia market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
- In terms of segment, primary was the largest revenue generating product in 2023.
- Primary is the most lucrative product segment registering the fastest growth during the forecast period.
Research antibodies market data book summary
| Market revenue in 2023 | USD 49.4 million |
| Market revenue in 2030 | USD 69.1 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | Primary |
| Fastest growing segment | Primary |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Primary, Secondary |
| Key market players worldwide | Abcam PLC, Merck KGaA, Thermo Fisher Scientific Inc, Cell Signaling Technology, PerkinElmer, Becton Dickinson & Co, Bio-Techne Corp, Proteintech Group |
Other key industry trends
- In terms of revenue, Australia accounted for 3.1% of the global research antibodies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China research antibodies market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 79.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research Antibodies Market Scope
Research Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia research antibodies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research antibodies market will help companies and investors design strategic landscapes.
Primary was the largest segment with a revenue share of 78.34% in 2023. Horizon Databook has segmented the Australia research antibodies market based on primary, secondary covering the revenue growth of each sub-segment from 2018 to 2030.
Rise in government investments in biotechnology sector is anticipated to boost the market in Australia. This project aims at expanding genomic technology and applied knowledge, facilitating increased life span of Australian citizens by funding new research, technologies, and clinical trials.
In May 2018, the government introduced reforms in its R&D tax initiative, which spared companies their lifetime caps on refunds. This initiative also exempted clinical trials cap on the annual refundable amount, easing regulatory policies for Australian-based companies.
Reasons to subscribe to Australia research antibodies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia research antibodies market databook
-
Our clientele includes a mix of research antibodies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia research antibodies market , including forecasts for subscribers. This country databook contains high-level insights into Australia research antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia research antibodies market size, by product, 2018-2030 (US$M)
Australia Research Antibodies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
